Skip to content
MatchScript
Menu

Head-to-head · The Match Score

Curex vs HydraMed

Both scored on the same six-factor Match Score. Curex wins this matchup with a 86 to 79 edge.

Higher Match Score

Curex

#8 · Grade B+

People who value a transparent, well-supported program with simple same-price-either-molecule billing.

Visit Curex
VS

HydraMed

#24 · Grade C

People in one of its eleven states who want a straightforward injectable program.

Visit HydraMed

Factor by factor

The six sub-scores behind each Match Score. The quiz reweights these to your priorities — one provider can pull ahead for you on the factors you care about.

Budget Fit
80
78
Speed to Start
88
74
Formulary Match
86
80
Support Level
88
82
Flexibility
86
82
Transparency
88
80

Price, coverage & formulary

DetailCurexHydraMed
Semaglutide$199/mo$179/mo
Tirzepatide$199/mo$319/mo
CoverageAll 50 statesCO, FL, TX, TN, GA, AZ, IL, NV, VA, MD, WY
Brand-name accessCompounded onlyCompounded only
Oral / sublingualYesInjectable only
Match Score86 · B+79 · C
Winner: Curex

Curex edges out HydraMed, 86 to 79 on the default Match Score. A high-disclosure program with identical flat pricing on both molecules, an oral route, and hands-on support.

HydraMed is still a fair pick if its strengths line up with yours — best for: People in one of its eleven states who want a straightforward injectable program.

Worth a look either way: our overall #1 pick is CoreAge Rx (Match Score 91) — nationwide access, both molecules at one flat price, easy to cancel. Or take the 6-question quiz to see your personalized match.

Assume any provider we list may compensate us, at no cost to you. It never changes the Match Score.

Full Curex reviewFull HydraMed review

More head-to-heads

Or browse alternatives to Curex and all comparisons.

Pricing, states and verification reflect each provider's public disclosures at last review; the Match Score and its sub-scores are our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.